Cargando…
The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids
BACKGROUND: Psoriasis is a chronic systemic inflammatory disease associated with a wide range of comorbidities, including metabolic syndrome (MetS). Serum calprotectin, ANGPTL8, and oxidative damage to nucleic acids might be associated with both diseases. The presented study describes the influence...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256681/ https://www.ncbi.nlm.nih.gov/pubmed/32537470 http://dx.doi.org/10.1155/2020/7352637 |
_version_ | 1783539965014048768 |
---|---|
author | Holmannova, Drahomira Borska, Lenka Andrys, Ctirad Borsky, Pavel Kremlacek, Jan Hamakova, Kvetoslava Rehacek, Vit Malkova, Andrea Svadlakova, Tereza Palicka, Vladimir Krejsek, Jan Fiala, Zdenek |
author_facet | Holmannova, Drahomira Borska, Lenka Andrys, Ctirad Borsky, Pavel Kremlacek, Jan Hamakova, Kvetoslava Rehacek, Vit Malkova, Andrea Svadlakova, Tereza Palicka, Vladimir Krejsek, Jan Fiala, Zdenek |
author_sort | Holmannova, Drahomira |
collection | PubMed |
description | BACKGROUND: Psoriasis is a chronic systemic inflammatory disease associated with a wide range of comorbidities, including metabolic syndrome (MetS). Serum calprotectin, ANGPTL8, and oxidative damage to nucleic acids might be associated with both diseases. The presented study describes the influence of psoriasis and MetS on the serum levels of markers of systemic inflammation (calprotectin and ANGPTL8) and markers of oxidative damage to nucleic acids. The applicability of serum levels of calprotectin and ANGPTL8 for monitoring of the activity of psoriasis (diagnostic markers) is also evaluated. METHODS: Clinical examination (PASI score, MetS), enzyme-linked immunosorbent assay (ELISA), and Enzyme Immunoassay (EIA). Serum calprotectin, ANGPTL8, 8-hydroxy-2′-deoxyguanosine, 8-hydroxyguanosine, and 8-hydroxyguanine. Results and Conclusions. The psoriasis significantly increased the serum level of calprotectin and the serum level of oxidative damage to nucleic acids, however not the serum level of ANGPTL8. The presence of MetS did not significantly affect the serum levels of calprotectin, ANGPTL8, and oxidative damage to nucleic acids in either psoriasis patients or controls. It seems that the serum level of calprotectin (but not the serum level of ANGPTL8) could be used as a biomarker for monitoring the activity of psoriasis. |
format | Online Article Text |
id | pubmed-7256681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-72566812020-06-13 The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids Holmannova, Drahomira Borska, Lenka Andrys, Ctirad Borsky, Pavel Kremlacek, Jan Hamakova, Kvetoslava Rehacek, Vit Malkova, Andrea Svadlakova, Tereza Palicka, Vladimir Krejsek, Jan Fiala, Zdenek J Immunol Res Research Article BACKGROUND: Psoriasis is a chronic systemic inflammatory disease associated with a wide range of comorbidities, including metabolic syndrome (MetS). Serum calprotectin, ANGPTL8, and oxidative damage to nucleic acids might be associated with both diseases. The presented study describes the influence of psoriasis and MetS on the serum levels of markers of systemic inflammation (calprotectin and ANGPTL8) and markers of oxidative damage to nucleic acids. The applicability of serum levels of calprotectin and ANGPTL8 for monitoring of the activity of psoriasis (diagnostic markers) is also evaluated. METHODS: Clinical examination (PASI score, MetS), enzyme-linked immunosorbent assay (ELISA), and Enzyme Immunoassay (EIA). Serum calprotectin, ANGPTL8, 8-hydroxy-2′-deoxyguanosine, 8-hydroxyguanosine, and 8-hydroxyguanine. Results and Conclusions. The psoriasis significantly increased the serum level of calprotectin and the serum level of oxidative damage to nucleic acids, however not the serum level of ANGPTL8. The presence of MetS did not significantly affect the serum levels of calprotectin, ANGPTL8, and oxidative damage to nucleic acids in either psoriasis patients or controls. It seems that the serum level of calprotectin (but not the serum level of ANGPTL8) could be used as a biomarker for monitoring the activity of psoriasis. Hindawi 2020-05-20 /pmc/articles/PMC7256681/ /pubmed/32537470 http://dx.doi.org/10.1155/2020/7352637 Text en Copyright © 2020 Drahomira Holmannova et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Holmannova, Drahomira Borska, Lenka Andrys, Ctirad Borsky, Pavel Kremlacek, Jan Hamakova, Kvetoslava Rehacek, Vit Malkova, Andrea Svadlakova, Tereza Palicka, Vladimir Krejsek, Jan Fiala, Zdenek The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title | The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title_full | The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title_fullStr | The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title_full_unstemmed | The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title_short | The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids |
title_sort | impact of psoriasis and metabolic syndrome on the systemic inflammation and oxidative damage to nucleic acids |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256681/ https://www.ncbi.nlm.nih.gov/pubmed/32537470 http://dx.doi.org/10.1155/2020/7352637 |
work_keys_str_mv | AT holmannovadrahomira theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT borskalenka theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT andrysctirad theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT borskypavel theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT kremlacekjan theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT hamakovakvetoslava theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT rehacekvit theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT malkovaandrea theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT svadlakovatereza theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT palickavladimir theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT krejsekjan theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT fialazdenek theimpactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT holmannovadrahomira impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT borskalenka impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT andrysctirad impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT borskypavel impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT kremlacekjan impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT hamakovakvetoslava impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT rehacekvit impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT malkovaandrea impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT svadlakovatereza impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT palickavladimir impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT krejsekjan impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids AT fialazdenek impactofpsoriasisandmetabolicsyndromeonthesystemicinflammationandoxidativedamagetonucleicacids |